HomeCompareRYMFX vs JNJ

RYMFX vs JNJ: Dividend Comparison 2026

RYMFX yields 5.60% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RYMFX wins by $8.9K in total portfolio value
10 years
RYMFX
RYMFX
● Live price
5.60%
Share price
$21.20
Annual div
$1.19
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.9K
Annual income
$800.61
Full RYMFX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RYMFX vs JNJ

📍 RYMFX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRYMFXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RYMFX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RYMFX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RYMFX
Annual income on $10K today (after 15% tax)
$476.00/yr
After 10yr DRIP, annual income (after tax)
$680.52/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $23.09/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RYMFX + JNJ for your $10,000?

RYMFX: 50%JNJ: 50%
100% JNJ50/50100% RYMFX
Portfolio after 10yr
$24.5K
Annual income
$814.19/yr
Blended yield
3.33%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RYMFX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RYMFX buys
0
JNJ buys
0
No recent congressional trades found for RYMFX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRYMFXJNJ
Forward yield5.60%3.36%
Annual dividend / share$1.19$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$28.9K$20.0K
Annual income after 10y$800.61$827.78
Total dividends collected$6.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RYMFX vs JNJ ($10,000, DRIP)

YearRYMFX PortfolioRYMFX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,260$560.00$10,676$355.77+$584.00RYMFX
2$12,637$589.30$11,407$389.39+$1.2KRYMFX
3$14,140$618.13$12,198$426.53+$1.9KRYMFX
4$15,776$646.38$13,056$467.62+$2.7KRYMFX
5$17,555$674.00$13,987$513.12+$3.6KRYMFX
6$19,485$700.91$14,998$563.56+$4.5KRYMFX
7$21,576$727.06$16,098$619.52+$5.5KRYMFX
8$23,838$752.42$17,295$681.69+$6.5KRYMFX
9$26,284$776.94$18,599$750.82+$7.7KRYMFX
10$28,924$800.61$20,022$827.78+$8.9KRYMFX

RYMFX vs JNJ: Complete Analysis 2026

RYMFXStock

The advisor intends to invest in multiple proprietary and third-party investment strategies that seek to identify and profit from upcoming movements in any combination of global fixed income, currency, commodity, or equity markets. It will invest at least 80% of its net assets, plus any borrowings for investment purposes, in "managed futures." It also may invest up to 25% of its assets in municipal securities. The fund may invest up to 25% of its total assets in a wholly-owned and controlled Cayman Islands subsidiary as measured at the end of every quarter of its taxable year.

Full RYMFX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RYMFX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RYMFX vs SCHDRYMFX vs JEPIRYMFX vs ORYMFX vs KORYMFX vs MAINRYMFX vs ABBVRYMFX vs MRKRYMFX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.